LICASTRO, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 4.919
EU - Europa 3.174
AS - Asia 1.729
AF - Africa 210
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 5
SA - Sud America 5
Totale 10.061
Nazione #
US - Stati Uniti d'America 4.910
GB - Regno Unito 999
CN - Cina 539
VN - Vietnam 508
DE - Germania 457
SE - Svezia 414
SG - Singapore 380
UA - Ucraina 357
IT - Italia 292
IN - India 192
FR - Francia 139
RU - Federazione Russa 132
IE - Irlanda 125
ZA - Sudafrica 64
EE - Estonia 62
JO - Giordania 61
CH - Svizzera 59
BG - Bulgaria 52
TG - Togo 50
CI - Costa d'Avorio 36
SC - Seychelles 36
BE - Belgio 26
FI - Finlandia 25
NG - Nigeria 23
EU - Europa 19
GR - Grecia 12
JP - Giappone 11
TR - Turchia 11
CA - Canada 8
PL - Polonia 7
LB - Libano 6
AU - Australia 4
IR - Iran 4
AT - Austria 3
BR - Brasile 3
ID - Indonesia 3
MD - Moldavia 3
UZ - Uzbekistan 3
CL - Cile 2
CZ - Repubblica Ceca 2
ES - Italia 2
KZ - Kazakistan 2
NL - Olanda 2
RO - Romania 2
SA - Arabia Saudita 2
BD - Bangladesh 1
BY - Bielorussia 1
DK - Danimarca 1
EG - Egitto 1
GL - Groenlandia 1
HK - Hong Kong 1
IL - Israele 1
LK - Sri Lanka 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
TH - Thailandia 1
Totale 10.061
Città #
Southend 878
Fairfield 672
Chandler 435
Dong Ket 432
Ashburn 351
Singapore 351
Seattle 331
Woodbridge 328
Wilmington 276
Jacksonville 268
Houston 254
Cambridge 235
Santa Clara 215
Ann Arbor 213
Princeton 194
Dublin 125
Boardman 112
Nanjing 91
Westminster 89
Padova 88
Berlin 62
Amman 61
New York 55
Bern 54
Sofia 52
Lomé 50
Mülheim 45
Saint Petersburg 45
Bremen 40
San Diego 38
Shenyang 38
Abidjan 36
Mahé 33
Hebei 31
Jinan 29
Beijing 28
Bologna 27
Brussels 26
Jiaxing 25
Helsinki 24
Nanchang 24
Abeokuta 23
Milan 23
Changsha 22
Des Moines 22
Pune 22
Turin 21
Norwalk 20
Dearborn 19
Tianjin 17
Verona 16
Olalla 15
Falls Church 13
Hangzhou 13
Mountain View 13
San Venanzo 13
Guangzhou 11
Tokyo 11
Haikou 10
Zhengzhou 10
Florence 9
Kunming 9
Shenzhen 9
Istanbul 8
Los Angeles 8
Lanzhou 7
Medford 7
Ningbo 7
Taizhou 7
Phoenix 6
Shanghai 6
Wenzhou 6
Bühl 5
Fuzhou 5
Genzano Di Roma 5
London 5
Paris 5
Qingdao 5
Taiyuan 5
Andover 4
Frankfurt Am Main 4
Harbin 4
Naples 4
Redmond 4
Washington 4
Xi'an 4
Baoding 3
Bari 3
Buffalo 3
Chengdu 3
Chicago 3
Clearwater 3
Costa Mesa 3
Jakarta 3
Plauen 3
Rome 3
San Francisco 3
São Paulo 3
Torino 3
Wuhan 3
Totale 7.269
Nome #
The 21st century epidemic: Infections as inductors of neuro-degeneration associated with Alzheimer's Disease 181
Alzheimer's disease gene signature says: beware of brain viral infections. 180
A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer's disease. 178
Altered glycosylation profile of purified plasma ACT from Alzheimer's disease. 172
Blood Inflammatory Proteins and Risk of Incident Depression in the Elderly. 171
Acute myocardial infarction and proinflammatory gene variants. Ann N Y Acad Sci. 2007 Nov;1119:227-42. 153
A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease. 152
Alpha 1 antichymotrypsin genotype is associated with increased risk of prostate carcinoma and PSA levels. 151
Blood inflammatory markers and risk of dementia: the Conselice study of brain aging. 144
APOE and Alzheimer disease: a major gene with semi-dominant inheritance. 144
ASSOCIATIONS OF THE -174 G/C INTERLEUKIN-6 GENE PROMOTER POLYMORPHISM WITH SERUM INTERLEUKIN -6 AND MORTALITY IN THE ELDERLY 142
Pathophysiology of age-related diseases 141
Adipocytokines in Down's syndrome, an atheroma-free model: Role of adiponectin 137
Apolipoprotein E genotypic frequencies among Down syndrome patients imply early unsuccessful aging for ApoE4 carriers. 136
Multi factorial interactions in the pathogenesis pathway of Alzheimer's disease: a new risk charts for prevention of dementia. 136
The G51S purine nucleoside phosphorylase polymorphism is associated with cognitive decline in Alzheimer's disease patients. 136
Altered vessel signalling molecules in subjects with Down's syndrome. 135
ASSOCIAZIONE DEL POLIMORFISMO NELLA REGIONE PROMOTRICE DEL GENE DELL’ALFA-1-ANTI-CHIMOTRIPSINA CON L’IPERTROFIA PROSTATICA BENIGNA ED IL CARCINOMA PROSTATICO 134
Apolipoprotein E e4 allele affects risk of hyperhomocysteinemia in the elderly. 134
Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart disease. 133
ANTI-DSDNA AUTOANTIBODIES IN SERUM OF DOWN’S SYNDROME PATIENTS 132
La concomitante presenza degli alleli dell'interleuchina-1beta, dell'interleuchina-6 e dell'apolipoproteina E è associata ad un elevato rischio di infarto al miocardio. 130
Pro-inflammatory genetic profile and familiarity of acute myocardial infarction. 126
Endogenous sex hormones as risk factors for dementia in elderly men and women. 125
Analysis of polymorphisms Leiden Factor V G1691A and prothrombin G20210A as risk factors for acute myocardial infarction. 125
Homocysteine and folate as risk factors for dementia and Alzheimer Disease. 124
NEOPTERIN LEVELS AND IMMUNE ACTIVATION IN THE BLOOD OF CHILDREN WITH DOWN’S SYNDROME 124
Sharing Pathogenetic Mechanisms between Acute Myocardial Infarction and Alzheimer's Disease as Shown by Partially Overlapping of Gene Variant Profiles. 124
Peripheral Inflammatory Markers and Antioxidant Response during the Post-Acute and Chronic Phase after Severe Traumatic Brain Injury. 124
Association between the polymorphism of CCR5 and Alzheimer's disease: results of a study performed on male and female patients from Northern Italy. 122
Gene-gene and gene - clinical factors interaction in acute myocardial infarction: a new detailed risk chart 120
Herpes virus in Alzheimer's disease: relation to progression of the disease 120
Genetic risk profiles for Alzheimer's disease: Integration of APOE genotype and variants that up-regulate inflammation. 119
Multivariable network associated with cognitive decline and dementia 119
Gene signature in Alzheimer's disease and environmental factors: the virus chronicle. 118
Monocyte chemoattractant protein-1 promoter polymorphism and plasma levels in alzheimer’s disease 118
Genetic factors regulating inflammation and DNA methylation associated with prostate cancer. 118
Immunobiologia, il sistema immunitario in stato di salute e malattia 117
Immunoproteasome and LMP2 polymorphism in aged and Alzheimer's disease brains 117
Age-related inflammatory diseases: role of genetics and gender in the pathophysiology of Alzheimer's disease. 116
Haplotype of single nucleotide polymorphisms in exon 6 of the MZF-1 gene and Alzheimer's disease. 114
alpha-1-Antichymotrypsin polymorphism in the gene promoter region affects survival and synapsis loss in Alzheimer's disease. 113
LDL RECEPTOR EXPRESSION ON T LYMPHOCYTES IN OLD PATIENTS WITH DOWN’S SYNDROME. 113
IS IMMUNOTHERAPY AN EFFECTIVE TREATMENT FOR ALZHEIMER’S DISEASE 111
The CALHM1 P86L Polymorphism is a Genetic Modifier of Age at Onset in Alzheimer's Disease: a Meta-Analysis Study. 111
Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men. 111
Variations in inflammatory genes are associated with periodontitis 111
Predictive diagnostics and personalized medicine for the prevention of chronic degenerative diseases. 110
The concomitant presence of polymorphic alleles of interleukin-1beta, interleukin-6 and apolipoprotein E is associated with an increased risk of myocardial infarction in elderly men. Results from a pilot study. 109
Association between the HLA-A2 allele and Alzheimer's disease. 109
Impaired regulation of immune responses in cognitive decline and Alzheimer's disease: lessons from genetic association studies 109
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. 109
Age-related changes in plasma levels of BDNF in Down syndrome patients. 109
Reduced plasma levels of P-selectin and L-selectin in a pilot study from Alzheimer disease: relationship with neuro-degeneration. 108
Peripheral leukocyte expression of the potential biomarker proteins Bdnf, Sirt1, and Psen1 is not regulated by promoter methylation in Alzheimer's disease patients 108
Variants in antiviral genes are risk factors for cognitive decline and dementia 108
ALTERED CYTOKINE AND ACUTE PHASE RESPONSE PROTEIN LEVELS IN THE BLOOD OF CHILDREN WITH DOWN’S SYNDOME: RELATIONSHIP WITH DEMENTIA OF ALZHEIMER’S TYPE 107
Association between the polymorphisms of TLR4 and CD14 genes and Alzheimer's disease. 107
Elevated plasma levels of alpha-1-antichymotripsin in age-related cognitive decline and Alzheimer's disease; a poential therapeutci target. 107
The hydroxy-methyl-glutaryl CoA reductase promoter polymorphism is associated with Alzheimer's risk and cognitive deterioration. 106
Polymorphisms of fas gene: relationship with Alzheimer's disease and cognitive decline 104
Oxidated low-density lipoproteins (oxLDL) and peroxides in plasma of Down syndrome patients. 103
DETERMINATION OF TELOMERE LENGTH BY FLOW-FLORESCENCE IN SITU HYBRIDIZATION IN DOWN’S SYNDROME PATIENTS 101
Interleukin-1beta and interleukin-6 gene polymorphisms as risk factors for AD: A prospective study. 101
Role of cyclooxygenase-2 and 5-lipoxygenase polymorphisms in Alzheimer's disease in a population from northern Italy: implication for pharmacogenomics. 100
Association between the interleukin-1beta polymorphisms and Alzheimer's disease: A systematic review and meta-analysis 98
Polymorphisms of pro-inflammatory genes and Alzheimer's disease risk: A pharmacogenomic approach. 97
Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations. 97
Does down's syndrome support the homocystein theory of atherosclerosis?experience in elderly subjects with trysomy 21. 96
Effetti del polimorfismo -174 G>C del gene promotore di interleuchina 6 (IL6) su livelli circolanti di IL6 e rischio di mortalità a 4 anni di follow-up: risultati dal Conselice Study of Brain Aging 94
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. 93
Tumor necrosis factor-alpha antagonists: differential clinical effects by different biotechnological molecules. 92
Effetti del polimorfismo -511 T>C del gene di interleuchina 1-beta (IL1B) e del polimorfismo -174 G>C del gene promotore di interleuchina 6 (IL6) sul rischio di demenza di Alzheimer a 4 anni di follow-up: risultati dal Conselice Sudy of Brain Aging. 91
Role of prothrombotic polymorphisms in successful or unsuccessful aging. 90
VEGF gene and phenotype relation with Alzheimer's disease and mild cognitive impairment. 90
Advanced oxidation protein products (AOPP) and high sensitivity C-reactiv protein (hS-CRP) in an 'atheroma free model' : Down's Syndrome. 89
Outcomes from a program of home care attendance in very frail elderly subjects. 88
FREE AND BOUND LEPTIN IN PREPUBERTAL CHILDREN WITH DOWN’S SYNDROME AND DIFFERENT DEGREES OF ADIPOSITY 88
Okadaic acid induces apoptosis in Down syndrome fibroblasts. 88
Compendio di patologia Generale 85
Serum neutrophil gelatinase-B associated lipocalin (NGAL) levels in Down's syndrome patients. 84
Innate immunity and inflammation in ageing: a key for understanding age-related diseases. 83
TRATTAMENTO PER MIGLIORARE LE PRESTAZIONI COGNITIVE DI PAZIENTI AFFETTI DA DEMENZA DI TIPO ALZHEIMER 82
Plasma nerve growth factor (NGF) and inflammatory cytokines (IL-6 and MCP-1) in young and adult subjects with Down syndrome: an interesting pathway. 82
Systematic review by meta-analyses on the possible role of TNF-alpha polymorphisms in association with Alzheimer's disease. 72
SHIP2: a "NEW" insulin pathway target for ageing research. 66
Tumor necrosis-factor-alpha -308 A/G polymorphism is associated with age at onset of Alzheimer's disease. 65
Erytrocyte glycohydrases in subjects with trisomy 21: could down's syndrome be a model of accellerrated ageing? 64
Impaired Innate Immunity Mechanisms in the Brain of Alzheimer's Disease. 54
Altered thymic endocrine activity along with impairments of peripheral zinc metabolism and T-lymphocyte populations are associated with myasthenia gravis: A follow-up study 26
Totale 10.181
Categoria #
all - tutte 23.431
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.431


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.093 0 0 0 0 287 316 325 397 323 181 95 169
2020/20211.517 296 101 44 80 38 72 16 80 82 102 78 528
2021/20221.574 162 43 169 152 145 91 40 116 46 55 319 236
2022/20231.907 210 258 99 231 146 136 52 82 325 141 136 91
2023/2024460 38 71 20 45 51 160 15 20 7 17 3 13
2024/2025934 32 325 114 129 334 0 0 0 0 0 0 0
Totale 10.181